NASDAQ Companies

WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) — Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted […]

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional […]

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based […]

BOSTON, April 12, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]

ROCHESTER, NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — Syntec Optics, a leading provider of mission-critical optics for scientific and […]

SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) — JOYY Inc. (Nasdaq: YY) (“JOYY” or the “Company”), a global technology company, today […]

NOVATO, Calif., April 12, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that preclinical and clinical data, […]

FOSTER CITY, Calif., April 12, 2024 (GLOBE NEWSWIRE) — Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage […]

In a preliminary review of blinded data from the ongoing TREK-DX study, 45% (10/22) of patients achieved at least a […]

NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) — GD Culture Group Limited (“GDC” or the “Company”) (Nasdaq: GDC) and its […]